GLP-1 therapies require a tightly controlled cold chain, where temperature stability, freeze protection, and packout precision directly affect product integrity. Because these biologics must remain within a strict 2–8°C range, organizations expanding into specialty pharmacy, direct-to-patient fulfillment, and other time-sensitive delivery models face increasing pressure to reduce excursion risk and strengthen compliance readiness. Seasonal variability, carrier delays, porch exposure, poor conditioning practices, and inconsistent packout execution can all introduce costly vulnerabilities, with freeze exposure remaining one of the most critical and preventable causes of product loss.

To help teams strengthen their approach, We have developed this free downloadable resource: GLP-1 Compliance & Packout Playbook.

This playbook outlines the core thermal, operational, and documentation considerations involved in shipping GLP-1 products more reliably, including: